Abstract:Portable NIR spectrometers are effective in detecting authentic pharmaceutical products in intact capsule formulations, which can be used to screen for substandard or falsified versions of those authentic products. However, the chemometric models are trained on libraries of authentic products, and are generally unreliable for detection of quality problems in products from outside their training set, even for products that are nominally the same active pharmaceutical ingredient and same dosage as products in the training set. As part of our research directed at developing better non-brand-specific strategies for pharmaceutical screening, we investigated the impact of capsule composition on NIR modeling. We found that capsule features like gelatin type, color, or thickness, give rise to a similar amount of variance in the NIR spectra as the type of API stored within the capsules. Our results highlight the efficacy of orthogonal projection to latent structures in mitigating the impacts of different types of capsules on the accuracy of NIR chemometric models for classification and regression analysis of lab-made samples. The models showed good performance for classification of field-collected doxycycline capsules as good or bad quality when an NIR-based % w/w metric was used, identifying five samples that were adulterated with talc. However, the % w/w was systematically underestimated, so when evaluating the capsules based on their absolute API content according to the monograph standard, the classification accuracy decreased from 100% to 70%. The underestimation was attributed to an unforeseen variability in the quantities and types of excipients present in the capsules.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the interference problem caused by the change in capsule composition when near - infrared spectroscopy (NIR) is used to detect drug quality. Specifically, the research aims to develop a robust NIR method for on - site screening of the quality of anti - infective drugs, especially for those drugs containing gelatin capsules of different types and thicknesses. The research focuses on how to reduce the influence of capsule material differences on NIR spectra through data pre - processing techniques, thereby improving the accuracy of the model in predicting the content of active pharmaceutical ingredients (API). ### Research Background and Objectives Near - infrared spectroscopy technology is particularly suitable for environments outside the laboratory in analytical applications because of its low cost, non - destructive, fast and multi - functional characteristics. However, the composition of the capsule (such as gelatin type, color or thickness) will introduce spectral variations of the same magnitude as the API, which makes the NIR - based chemometric model face challenges when detecting drug quality. Therefore, the main objectives of the research are: 1. **Reduce the influence of capsule material differences on NIR spectra**: By using different data pre - processing techniques (such as standard normal variate transformation (SNV), Savitzky - Golay filtering and orthogonal partial least squares (O - PLS)), reduce the spectral variations caused by capsule materials and improve the prediction accuracy of the NIR model. 2. **Develop a general drug screening strategy**: The research aims to develop a general strategy that does not depend on specific brand products to improve the application range and reliability of NIR technology in drug quality control. 3. **Evaluate the performance of the model in on - site samples**: By applying the NIR model to doxycycline capsule samples collected from Kenya and Liberia and comparing with the results of high - performance liquid chromatography (HPLC), evaluate the performance of the model under on - site conditions. ### Method Overview 1. **Sample preparation**: The researchers prepared mixtures of different APIs and excipients and encapsulated them in gelatin capsules of different colors and compositions. 2. **NIR data acquisition**: Use a portable NIR spectrometer to obtain the spectral data of the samples. 3. **Data pre - processing**: Use methods such as SNV, SG and O - PLS to pre - process the NIR spectra to reduce the spectral variations caused by capsule materials. 4. **Model building and validation**: Use multivariate data analysis methods such as support vector machine regression (SVM - R) and partial least squares regression (PLS - R) to build models, and optimize model parameters through techniques such as cross - validation and K - fold cross - validation. 5. **On - site sample testing**: Apply the established model to doxycycline capsule samples collected from Kenya and Liberia to evaluate the performance of the model under on - site conditions. ### Main Findings - **The influence of capsule materials on NIR spectra**: The research found that the color, thickness and composition of the capsule significantly affect the NIR spectra, and the variations introduced by these factors are comparable to those caused by the API itself. - **The effectiveness of data pre - processing**: Through pre - processing methods such as SNV, SG and O - PLS, the spectral variations caused by capsule materials can be effectively reduced, and the prediction accuracy of the model can be improved. - **Results of on - site sample testing**: The model performs well in on - site samples and can identify samples doped with talc powder, but there is a problem of systematic underestimation in the prediction of the absolute API content. ### Conclusion This research successfully demonstrates that by using data pre - processing techniques to reduce the spectral variations caused by capsule materials, the application potential of NIR technology in drug quality control is improved. However, the research also points out that further optimizing model parameters and improving data pre - processing methods to improve the accuracy of predicting the absolute API content will be an important direction for future research.

Mitigating the impact of gelatin capsule variability on detection of substandard and falsified pharmaceuticals with near-IR spectroscopy